I snuck in a couple extra stories on two of our local scholar-athletes in a special section that ran in today’s paper. Stonington’s Conrad Tobiassen and New London’s Kmara Royster.
Pfizer has never been more focused on turning bold, scientific ideas into innovative medicines. Today, we shared positive topline results from a Phase 3 study of a potential oral, once-a-day therapy for patients with moderate to severe ulcerative colitis: https://t.co/481QZfCN8y
Tuesday night I tuned in to the Presidential debate and was disappointed that #COVID19 was discussed in political rather than scientific terms. Public trust and acceptance of a vaccine is so important that I sent this letter to US colleagues earlier today. https://t.co/ipXZ8ydXJa